|
Status |
Public on Nov 26, 2019 |
Title |
3_ATRA+GSK-LSD1 |
Sample type |
SRA |
|
|
Source name |
acute myeloid leukemia
|
Organism |
Homo sapiens |
Characteristics |
cell type: HL-60 perturbation: ATRA (100 nM)
|
Treatment protocol |
1.5 x 10^6 cells were treated with respective compounds for 3 hours.
|
Growth protocol |
Cells were cultured in humidified incubator at 37°C and 5% CO2 in RPMI 1640 (supplemented: 1 mM sodium pyruvate, 10% FCS).
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was isolated and purified using Direct-zol™ RNA Kit (Zymo Research) Library preparation was done using Illumina's TruSeq Stranded mRNA Library Preparation Kit following the manufacturer's instruction.
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 2500 |
|
|
Data processing |
Basecalls performed using bcl2FastQ v1.8.4. Reads were aligned to the hg19 genome assembly using HISAT2. Gene counts were quantified using htseq-count. Genome_build: GRCh37/hg19 and respective gene annotation. Supplementary_files_format_and_content: The Excel file includes raw counts of all genes for each sample.
|
|
|
Submission date |
Dec 27, 2018 |
Last update date |
Nov 26, 2019 |
Contact name |
Marco Groth |
E-mail(s) |
dnaseq@leibniz-fli.de
|
Organization name |
Leibniz Institute on Aging - FLI
|
Department |
Core Facility - Next Generation Sequencing
|
Street address |
Beutenbergstraße 11
|
City |
Jena |
ZIP/Postal code |
07747 |
Country |
Germany |
|
|
Platform ID |
GPL16791 |
Series (2) |
GSE124422 |
RNA-seq of HL-60 cells following treatment with different compounds |
GSE124423 |
HL-60 cells following treatment with different compounds |
|
Relations |
BioSample |
SAMN10655790 |
SRA |
SRX5184923 |